Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home    

Healthcare Market Research Reports

PRODUCT TITLE PUBLISHED
European High content analysis/Screening European High content analysis/Screening
The European High Content Screening market was valued at $124.29 million in 2013 and is expected to reach $207.9 million by 2018, growing at a CAGR of 10.6% from 2013 to 2018. High Content Screening market segmentation primarily based on product types, the market is categorized into instruments (Imaging and Analysis HCS Systems, Flow Cytometers), consumables (Reagents and Assay kits, Microplates and other consumables) , software, and services. Based on applications, the high content screening market is segmented into primary and secondary screening, target identification and validation, toxicity studies, and compound profiling. Among the various end users of high content screening, pharmaceutical and biotechnology companies lead the market. Major players in the market include Thermo Fisher Scientific (U.S.), Molecular Devices (U.S.), PerkinElmer (U.S.), and GE Healthcare (U.K), Olympus (Japan), Life Technologies (U.S.), EMD Millipore (Germany), BD Bioscience (U.S.), Definiens AG (Germany), Yokogawa Electric Corporation (Japan), and TTP Labtech (U.S).
Upcoming
North American Oral Drug Delivery Market North American Oral Drug Delivery Market
The North American Oral Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $29.0 billion in 2013 and expected to be $43.7 billion by 2018, growing at a CAGR of 8.6%. The Oral Drug Delivery Market analyzes the market by segments such as Controlled Release, ODT and Taste Masking, Other Oral drug delivery technologies. The prominent players in the Market are Aptalis Pharmaceutical Technologies, Sky Pharma PLC, Tapemark, Baxter International Inc., Hovione Ltd.
Upcoming
Asian High content analysis/Screening Asian High content analysis/Screening
The Asian High Content Screening market was valued at $55.75 million in 2013 and is expected to reach $101.74 million by 2018, growing at a CAGR of 12.8% from 2013 to 2018.High Content Screening market segmentation primarily based on product types, the market is categorized into instruments (Imaging and Analysis HCS Systems, Flow Cytometers), consumables (Reagents and Assay kits, Microplates and other consumables) , software, and services. Based on applications, the high content screening market is segmented into primary and secondary screening, target identification and validation, toxicity studies, and compound profiling. Among the various end users of high content screening, pharmaceutical and biotechnology companies lead the market. Major players in the market include Thermo Fisher Scientific (U.S.), Molecular Devices (U.S.), PerkinElmer (U.S.), and GE Healthcare (U.K), Olympus (Japan), Life Technologies (U.S.), EMD Millipore (Germany), BD Bioscience (U.S.), Definiens AG (Germany), Yokogawa Electric Corporation (Japan), and TTP Labtech (U.S).
Upcoming
European Oral Drug Delivery Market European Oral Drug Delivery Market
The European Oral Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $16.9 billion in 2013 and expected to be $24.6 billion by 2018, growing at a CAGR of 7.7%. The Oral Drug Delivery Market analyzes the market by segments such as Controlled Release, ODT and Taste Masking, Other Oral drug delivery technologies. The prominent players in the Market are Aptalis Pharmaceutical Technologies, Sky Pharma PLC, Tapemark, Baxter International Inc., Hovione Ltd.
Upcoming
Asian Oral Drug Delivery Market Asian Oral Drug Delivery Market
The Asian Oral Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $10.9 billion in 2013 and expected to be $19.8 billion by 2018, growing at a CAGR of 12.7%. The Oral Drug Delivery Market analyzes the market by segments such as Controlled Release, ODT and Taste Masking, Other Oral drug delivery technologies. The prominent players in the Market are Aptalis Pharmaceutical Technologies, Sky Pharma PLC, Tapemark, Baxter International Inc., Hovione Ltd.
Upcoming
North American High throughput screening North American High throughput screening
The North American High Throughput Screening market was valued at $6454.3 million in 2013 and is expected to reach $9046.8 million by 2018, growing at a CAGR of 7.0% from 2013 to 2018. High Throughput Screening market is primarily categorized by technology, product, end user, and application. By technology, the HTS market is categorized into ultra high throughput screening (uHTS), cell-based assays, lab-on-a-chip, label-free technology, and bioinformatics. By product, the HTS market is segmented into instruments, consumables/reagents, and software and services. By end user, the High Throughput Screening market is categorized into pharmaceutical, biotechnology, academia and government, contract research organizations, and others. By application, the High Throughput Screening market is classified into target identification, primary screening, toxicology, stem cell biology, and others. Major players in the market include Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.) and Tecan Group (Switzerland).
Upcoming
European High throughput screening European High throughput screening
The European High Throughput Screening market was valued at $3794.7 million in 2013 and is expected to reach $5194.3 million by 2018, growing at a CAGR of 6.5% from 2013 to 2018. High Throughput Screening market is primarily categorized by technology, product, end user, and application. By technology, the HTS market is categorized into ultra high throughput screening (uHTS), cell-based assays, lab-on-a-chip, label-free technology, and bioinformatics. By product, the HTS market is segmented into instruments, consumables/reagents, and software and services. By end user, the High Throughput Screening market is categorized into pharmaceutical, biotechnology, academia and government, contract research organizations, and others. By application, the High Throughput Screening market is classified into target identification, primary screening, toxicology, stem cell biology, and others. Major players in the market include Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.) and Tecan Group (Switzerland).
Upcoming
Asian High throughput screening Asian High throughput screening
The Asian High Throughput Screening market was valued at $2547.3 million in 2013 and is expected to reach $3931.2 million by 2018, growing at a CAGR of 9.1% from 2013 to 2018. High Throughput Screening market is primarily categorized by technology, product, end user, and application. By technology, the HTS market is categorized into ultra high throughput screening (uHTS), cell-based assays, lab-on-a-chip, label-free technology, and bioinformatics. By product, the HTS market is segmented into instruments, consumables/reagents, and software and services. By end user, the High Throughput Screening market is categorized into pharmaceutical, biotechnology, academia and government, contract research organizations, and others. By application, the High Throughput Screening market is classified into target identification, primary screening, toxicology, stem cell biology, and others. Major players in the market include Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.) and Tecan Group (Switzerland).
Upcoming
North American Transdermal Drug Delivery Systems Market North American Transdermal Drug Delivery Systems Market
The North American Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies.The Market was Valued at $7.6 billion in 2013 and expected to be $12.7 billion by 2018, growing at a CAGR of 10.9%. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
European Transdermal Drug Delivery Systems Market European Transdermal Drug Delivery Systems Market
The European Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies.The Market was Valued at $3.6 billion in 2013 and expected to be $5.8 billion by 2018, growing at a CAGR of 9.9 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
Asian Transdermal Drug Delivery Systems Market Asian Transdermal Drug Delivery Systems Market
The Asian Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies.The Market was Valued at $1.5 billion in 2013 and expected to be $3.0 billion by 2018, growing at a CAGR of 14.8 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
North American Clinical Trial Management Systems (CTMS) Market North American Clinical Trial Management Systems (CTMS) Market
The North American Clinical Trial Management Systems Market is mainly driven by increasing R&D investment in pharmaceutical, life science and clinical research industries, Integration of CTMS with HIS, and rising prevalence of diseases and increased clinical research outsourcing.The Market was valued at $548.32 million in 2013 and expected to be $1107.57 million by 2018, growing at a CAGR of 15%. The Clinical Trial Management Systems Market analyzes the market by 2 segments such as Enterprise CTMS, and Site CTMS.The prominent players in the Clinical Trial Management Systems Market are Oracle Corporation, Perceptive Informatics (PAREXEL), Medidata Solutions, eResearch Technology Solutions, Bioclinica, Datatrak international inc., Pharmaceutical Product Development, LLC.
Upcoming
European Clinical Trial Management Systems (CTMS) Market European Clinical Trial Management Systems (CTMS) Market
The European Clinical Trial Management Systems Market is mainly driven by increasing R&D investment in pharmaceutical, life science and clinical research industries, Integration of CTMS with HIS, and rising prevalence of diseases and increased clinical research outsourcing.The Market was valued at $242.9 million in 2013 and expected to be $466 million by 2018, growing at a CAGR of 13.9%. The Clinical Trial Management Systems Market analyzes the market by 2 segments such as Enterprise CTMS, and Site CTMS.The prominent players in the Clinical Trial Management Systems Market are Oracle Corporation, Perceptive Informatics (PAREXEL), Medidata Solutions, eResearch Technology Solutions, Bioclinica, Datatrak international inc., Pharmaceutical Product Development, LLC.
Upcoming
Asian Clinical Trial Management Systems (CTMS) Market Asian Clinical Trial Management Systems (CTMS) Market
The Asian Clinical Trial Management Systems Market is mainly driven by increasing R&D investment in pharmaceutical, life science and clinical research industries, Integration of CTMS with HIS, and rising prevalence of diseases and increased clinical research outsourcing.The Market was valued at $63.8 million in 2013 and expected to be $133.9 million by 2018, growing at a CAGR of 16%. The Clinical Trial Management Systems Market analyzes the market by 2 segments such as Enterprise CTMS, and Site CTMS.The prominent players in the Clinical Trial Management Systems Market are Oracle Corporation, Perceptive Informatics (PAREXEL), Medidata Solutions, eResearch Technology Solutions, Bioclinica, Datatrak international inc., Pharmaceutical Product Development, LLC.
Upcoming
Asian Cleansing solutions Market Asian Cleansing solutions Market
The Asian Cleansing solutions Market was valued at $14 million in 2013 and expected to be $17 million by 2018, growing at a CAGR of 3.4%. The report “Asian Cleansing solutions Market forecast, 2012-2018 “analyzes the market of Cleansing solutions by 5 segments such as normal saline solutions, povidone solutions, hydrogen peroxide cleansers, sodium hypochlorite (Dakin solutions) and commercial cleansers. The main companies operating in cleansing solutions market and extensively covered in this report are Johnson and Johnson, Smith & Nephew, 3M healthcare, Derma Sciences, Covidien and Molnlycke healthcare and others.
Upcoming
European Cleansing solutions Market European Cleansing solutions Market
The European Cleansing solutions Market was valued at $23 million in 2013 and expected to be $24 million by 2018, growing at a CAGR of 1.5%. The report “European Cleansing solutions Market forecast, 2012-2018 “analyzes the market of Cleansing solutions by 5 segments such as normal saline solutions, povidone solutions, hydrogen peroxide cleansers, sodium hypochlorite (Dakin solutions) and commercial cleansers. The main companies operating in this market and extensively covered in this report are Smith & Nephew, 3M healthcare, Johnson and Johnson, Derma Sciences, Covidien, Molnlycke healthcare and others.
Upcoming
North American Cleansing solutions Market North American Cleansing solutions Market
The North American Cleansing solutions Market was valued at $69 million in 2013 and expected to be $76 million by 2018, growing at a CAGR of 2.0%. The report “Cleansing solutions Market forecast, 2012-2018 “analyzes the market of Cleansing solutions by 5 segments such as normal saline solutions, povidone solutions, hydrogen peroxide cleansers, sodium hypochlorite (Dakin solutions) and commercial cleansers. The main companies operating in this market and extensively covered in this report are Smith & Nephew, 3M healthcare, Johnson and Johnson, Derma Sciences, Covidien, Molnlycke healthcare and others.
Upcoming
Asian Picture Archiving and Communication System (PACS) Asian Picture Archiving and Communication System (PACS)
The Asian Picture Archiving and Communication System (PACS) Market was pegged at $456 million in 2012 and expected to be $675 million by 2018, growing at a CAGR of 6.74%.Picture Archiving and Communication System (PACS) Market can be segmented by Geographies, Applications, Deployments, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players  of this market have been considered in this report.  
Upcoming
North America Enzyme Immunoassays (EIA) North America Enzyme Immunoassays (EIA)
The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. The U.S. commanded the largest share of the Americas enzyme immunoassays market. The report “North American Enzyme immunoassays (EIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.
Upcoming
Europe Enzyme Immunoassays (EIA) Europe Enzyme Immunoassays (EIA)
The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. Germany commanded the largest share of the European enzyme immunoassays market. The report “European Enzyme immunoassays (EIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications.
Upcoming
2983 reports | Show
Connect With Us
US/CAN : +1-888-502-0539